Quick Answer
Cerence Inc. reported Research And Development Expense of $97.76 million for the year ending 2025.
- Cerence Inc. showed a decrease of -19.6% in Research And Development Expense from 2024 to 2025.
- This data is from Cerence Inc.'s annual report (Form 10-K), filed with the SEC on November 20, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2018: $23.81 million | Q1 2019: $22.56 million | Q2 2019: $22.98 million | Q4 2019: $23.51 million | Q1 2020: $21.35 million | Q2 2020: $22.04 million | Q4 2020: $24.13 million | Q1 2021: $28.86 million | Q2 2021: $30.37 million | Q4 2021: $25.79 million | Q1 2022: $29.98 million | Q2 2022: $26.04 million | Q4 2022: $29.49 million | Q1 2023: $28.49 million | Q2 2023: $30.20 million | Q4 2023: $33.31 million | Q1 2024: $31.85 million | Q2 2024: $31.18 million | Q4 2024: $20.87 million | Q1 2025: $23.33 million | Q2 2025: $27.15 million | Q4 2025: $24.70 million.
- Over the full 8 years of available data (2018 to 2025), Cerence Inc.'s Research And Development Expense has grown by 20.8%.
- Historical annual values: Fiscal year 2025: $97.76 million | Fiscal year 2024: $121.56 million | Fiscal year 2023: $123.33 million | Fiscal year 2022: $107.12 million | Fiscal year 2021: $112.07 million | Fiscal year 2020: $88.90 million | Fiscal year 2019: $93.06 million | Fiscal year 2018: $80.96 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: